Organigram blames weak sales on delayed value product launch

Mugglehead
By Jared GnamJul 21, 2020, 5:07 pm247 pts
Canadians want cheap weed and OrganiGram Holdings, Inc. (TSX: OGI) says the Covid-19 pandemic has delayed its ability to meet that demand. On Tuesday, the Moncton-based producer reported earnings for the third quarter ending May 31, booking a net loss of $90 million on net sales of $22.2 million. The company…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Pura Vida! Costa Rica officially starts medical cannabis rollout after years of delays 69

Top Cannabis Brand Rove Launches in Maryland With Award-Winning Vapes 63

Liquid Gold: Why THC Honey Oil Is the MVP of Cannabis Concentrates 55

Is ICE leading weed raids? 29

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.